Ligand Pharmaceuticals LGND Goodwill and intangible assets, net
Goodwill and intangible assets, net at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetIncludingGoodwill.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's goodwill and intangible assets, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's goodwill and intangible assets, net?
- Ligand Pharmaceuticals (LGND) reported goodwill and intangible assets, net of $318.88M in Q1 2026.
- How has Ligand Pharmaceuticals's goodwill and intangible assets, net changed year-over-year?
- Ligand Pharmaceuticals's goodwill and intangible assets, net decreased by 11.4% year-over-year, from $359.93M to $318.88M.
- What is the long-term trend for Ligand Pharmaceuticals's goodwill and intangible assets, net?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's goodwill and intangible assets, net has grown at a -16.1% compound annual growth rate (CAGR), from $784.99M to $326.98M.